Does ethnicity matter in male hormonal contraceptive efficacy?

Asian Journal of Andrology

Volumn 13, Issue 4, 2011, Pages 579-584

  Ilani, Niloufar ^a   Liu, Peter Y ^b   Swerdloff, Ronald S ^a   Wang, Christina ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

azoospermia; male contraception; progestin; suppression of spermatogenesis; testosterone

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; GESTAGEN; LUTEINIZING HORMONE; MALE CONTRACEPTIVE AGENT; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

APOPTOSIS; AZOOSPERMIA; CONTRACEPTION; CULTURAL FACTOR; DRUG EFFICACY; DRUG IMPLANT; DRUG SAFETY; ETHNIC DIFFERENCE; ETHNIC GROUP; ETHNICITY; GENETIC POLYMORPHISM; GERM CELL; HEALTH SURVEY; HORMONAL CONTRACEPTION; HUMAN; INJECTION; MALE; NEGATIVE FEEDBACK; PATIENT COMPLIANCE; PILL; REVIEW; SPERMATOGENESIS;

ASIAN CONTINENTAL ANCESTRY GROUP; AZOOSPERMIA; CONTRACEPTION; CONTRACEPTIVE AGENTS, MALE; CONTRACEPTIVES, ORAL, HORMONAL; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; PATIENT SATISFACTION; PROGESTINS; SPERMATOGENESIS; TESTOSTERONE;

EID: 79960073500     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2010.133     Document Type: Review

References (56)

1. Amory JK, Bremner W. Endocrine regulation of testicular function in men: implications for contraceptive development. Mol Cell Endocrinol 2002; 186: 205-9. (Pubitemid 34233715)
2. Wang C, Swerdloff RS. Male hormonal contraception. Am J Obstet Gynecol 2004; 190: S60-8. (Pubitemid 38561495)
3. Nieschlag E, Henke A. Hopes for male contraception. Lancet 2005; 365: 554-6. (Pubitemid 40247896)
4. Anderson RA, Baird DT. Male contraception. Endocr Rev 2002; 23: 735-62. (Pubitemid 36001999)
5. Kamischke A, Nieschlag E. Progress towards hormonal male contraception. Trends Pharmacol Sci 2004; 25: 49-57. (Pubitemid 38076956)
6. Page ST, Amory JK, Bremner WJ. Advances in male contraception. Endocr Rev 2008; 29: 465-93. (Pubitemid 351831509)
7. Nieschlag E. Clinical trials in male hormonal contraception. Contraception 2010; 82: 457-70.
8. ODonnell L, McLachlan RI, Wreford NG, de Kretser DM, Robertson DM. Testosterone withdrawal promotes stage-specific detachment of round spermatids from the rat seminiferous epithelium. Biol Reprod 1996; 55: 895-901. (Pubitemid 26304769)
9. ODonnell L, Narula A, Balourdos G, Gu YQ, Wreford NG et al. Impairment of spermatogonial development and spermiation after testosterone-induced gonadotropin suppression in adult monkeys (Macaca fascicularis). J Clin Endocrinol Metab 2001; 86: 1814-22. (Pubitemid 32374943)
10. McLachlan RI, ODonnell L, Meachem SJ, Stanton PG, de Kretser DM et al. Identification of specific sites of hormonal regulation in spermatogenesis in rats, monkeys, and man. Recent Prog Horm Res 2002; 57: 149-79.
11. McLachlan RI, ODonnell L, Meachem SJ, Stanton PG, de Kretser DM et al. Hormonal regulation of spermatogenesis in primates and man: insights for development of the male hormonal contraceptive. J Androl 2002; 23: 149-62. (Pubitemid 34169269)
12. Sinha Hikim AP, Rajavashisth TB, Sinha HI, Lue Y, Bonavera JJ et al. Significance of apoptosis in the temporal and stage-specific loss of germ cells in the adult rat after gonadotropin deprivation. Biol Reprod 1997; 57: 1193-201. (Pubitemid 27461213)
13. Hikim AP, Wang C, Leung A, Swerdloff RS. Involvement of apoptosis in the induction of germ cell degeneration in adult rats after gonadotropin-releasing hormone antagonist treatment. Endocrinology 1995; 136: 2770-5.
14. Vera Y, Erkkila K, Wang C, Nunez C, Kyttanen S et al. Involvement of p38 mitogenactivated protein kinase and inducible nitric oxide synthase in apoptotic signaling of murine and human male germ cells after hormone deprivation. Mol Endocrinol 2006; 20: 1597-609. (Pubitemid 43967567)
15. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility. Lancet 1990; 336: 955-9.
16. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 1996; 65: 821-9.
17. Turner L, Conway AJ, Jimenez M, Liu PY, Forbes E et al. Contraceptive efficacy of a depot progestin and androgen combination in men. J Clin Endocrinol Metab 2003; 88: 4659-67. (Pubitemid 37357508)
18. Gu Y, Liang X, Wu W, Liu M, Song S et al. Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men. J Clin Endocrinol Metab 2009; 94: 1910-5.
19. Gu YQ, Wang XH, Xu D, Peng L, Cheng LF et al. A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men. J Clin Endocrinol Metab 2003; 88: 562-8. (Pubitemid 36207791)
20. Handelsman DJ. Editorial: hormonal male contraception-lessons from the East when the Western market fails. J Clin Endocrinol Metab 2003; 88: 559-61. (Pubitemid 36207790)
21. Nieschlag E. Male hormonal contraception: loves labours lost? J Clin Endocrinol Metab 2009; 94: 1890-2.
22. Glasier AF, Anakwe R, Everington D, Martin CW, van der Spuy Z et al. Would women trust their partners to use a male pill? Hum Reprod 2000; 15: 646-9.
23. Martin CW, Anderson RA, Cheng L, Ho PC, van der Spuy Z et al. Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations. Hum Reprod 2000; 15: 637-45. (Pubitemid 30142376)
24. Heinemann K, Saad F, Wiesemes M, White S, Heinemann L. Attitudes toward male fertility control: results of a multinational survey on four continents. Hum Reprod 2005; 20: 549-56. (Pubitemid 40277631)
25. Handelsman DJ, Farley TM, Peregoudov A, Waites GM. Factors in nonuniform induction of azoospermia by testosterone enanthate in normal men. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Fertil Steril 1995; 63: 125-33.
26. Wu FC, Farley TM, Peregoudov A, Waites GM. Effects of testosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Fertil Steril 1996; 65: 626-36. (Pubitemid 26069123)
27. Liu PY, Swerdloff RS, Anawalt BD, Anderson RA, Bremner WJ et al. Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis. J Clin Endocrinol Metab 2008; 93: 1774-83. (Pubitemid 351656517)
28. Sitruk-Ware R. New progestagens for contraceptive use. Hum Reprod Update 2006; 12: 169-78. (Pubitemid 43231449)
29. Liu PY, Swerdloff RS, Christenson PD, Handelsman DJ, Wang C et al. Rate, extent and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet 2006; 367: 1412-20.
30. Turner L, Conway AJ, Jimenez M, Liu PY, Forbes E et al. Contraceptive efficacy of a depot progestin and androgen combination in men. J Clin Endocrinol Metab 2003; 88: 4659-67. (Pubitemid 37357508)
31. Johnson L, Barnard JJ, Rodriguez L, Smith EC, Swerdloff RS et al. Ethnic differences in testicular structure and spermatogenic potential may predispose testes of Asian men to a heightened sensitivity to steroidal contraceptives. J Androl 1998; 19: 348-57. (Pubitemid 28265112)
32. Handelsman DJ, Staraj S. Testicular size: the effects of aging, malnutrition, and illness. J Androl 1985; 6: 144-51.
33. Hikim AP, Wang C, Lue Y, Johnson L, Wang XH et al. Spontaneous germ cell apoptosis in humans: evidence for ethnic differences in the susceptibility of germ cells to programmed cell death. J Clin Endocrinol Metab 1998; 83: 152-6. (Pubitemid 28498327)
34. Santner SJ, Albertson B, Zhang GY, Zhang GH, Santulli M et al. Comparative rates of androgen production and metabolism in Caucasian and Chinese subjects. J Clin Endocrinol Metab 1998; 83: 2104-9. (Pubitemid 28496344)
35. Wang C, Catlin DH, Starcevic B, Leung A, DiStefano E et al. Testosterone metabolic clearance and production rates determined by stable isotope dilution/tandem mass spectrometry in normal men: influence of ethnicity and age. J Clin Endocrinol Metab 2004; 89: 2936-41. (Pubitemid 38766388)
36. Lookingbill DP, Demers LM, Wang C, Leung A, Rittmaster RS et al. Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects. J Clin Endocrinol Metab 1991; 72: 1242-8. (Pubitemid 21921835)
37. Wu AH, Whittemore AS, Kolonel LN, John EM, Gallagher RP et al. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African- American, white, and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev 1995; 4: 735-41.
38. Ross RK, Bernstein L, Lobo RA, Shimizu H, Stanczyk FZ et al. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 1992; 339: 887-9.
39. Orwoll ES, Nielson CM, Labrie F, Barrett-Connor E, Cauley JA et al. Evidence for geographical and racial variation in serum sex steroid levels in older men. J Clin Endocrinol Metab 2010; 95: E151-60.
40. Schulze JJ, Lundmark J, Garle M, Skilving I, Ekstrom L et al. Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation. J Clin Endocrinol Metab 2008; 93: 2500-6. (Pubitemid 352008513)
41. Swanson C, Mellstrom D, Lorentzon M, Vandenput L, Jakobsson J et al. The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men. J Clin Endocrinol Metab 2007; 92: 4878-82. (Pubitemid 350223472)
42. Jakobsson J, Ekstrom L, Inotsume N, Garle M, LorentzonM et al. Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDPglucuronosyl transferase 2B17 polymorphism. J Clin Endocrinol Metab 2006; 91: 687-93. (Pubitemid 43236944)
43. Vandenput L, Labrie F, Mellstrom D, Swanson C, Knutsson T et al. Serum levels of specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men. J Bone Miner Res 2007; 22: 220-7. (Pubitemid 46167792)
44. Xue Y, Sun D, Daly A, Yang F, Zhou X et al. Adaptive evolution of UGT2B17 copynumber variation. Am J Hum Genet 2008; 83: 337-46.
45. Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D et al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer [published erratum appears in Proc Natl Acad Sci USA 1997 Jul 22;94(15):8272]. Proc Natl Acad Sci USA 1997; 94: 3320-3. (Pubitemid 27157309)
46. Esteban E, Rodon N, Via M, Gonzalez-Perez E, Santamaria J et al. Androgen receptor CAG and GGC polymorphisms in Mediterraneans: repeat dynamics and population relationships. J Hum Genet 2006; 51: 129-36. (Pubitemid 43155457)
47. Yu B, Handelsman DJ. Pharmacogenetic polymorphisms of the AR and metabolism and susceptibility to hormone-induced azoospermia. J Clin Endocrinol Metab 2001; 86: 4406-11. (Pubitemid 32848566)
48. Eckardstein SV, Schmidt A, Kamischke A, Simoni M, Gromoll J et al. CAG repeat length in the androgen receptor gene and gonadotrophin suppression influence the effectiveness of hormonal male contraception. Clin Endocrinol (Oxf) 2002; 57: 647-55. (Pubitemid 35316983)
49. Li JW, Gu YQ. Predictors for partial suppression of spermatogenesis of hormonal male contraception. Asian J Androl 2008; 10: 723-30.
50. Wang C, Berman NG, Veldhuis JD, Der T, McDonald V et al. Graded testosterone infusions distinguish gonadotropin negative-feedback responsiveness in Asian and white men-a Clinical Research Center study. J Clin Endocrinol Metab 1998; 83: 870-6. (Pubitemid 28496459)
51. Attardi BJ, Hild SA, Reel JR. Dimethandrolone undecanoate: a new potent orally active androgen with progestational activity. Endocrinology 2006; 147: 3016-26. (Pubitemid 43764637)
52. Cook CE, Kepler JA. 7alpha,11beta-Dimethyl-19-nortestosterone: a potent and selective androgen response modulator with prostate-sparing properties. Bioorg Med Chem Lett 2005; 15: 1213-6. (Pubitemid 40476068)
53. Attardi BJ, Pham TC, Radler LC, Burgenson J, Hild SA et al. Dimethandrolone (7alpha,11beta-dimethyl-19-nortestosterone) and 11beta-methyl-19-nortestosterone are not converted to aromatic A-ring products in the presence of recombinant human aromatase. J Steroid Biochem Mol Biol 2008; 110: 214-22. (Pubitemid 351799973)
54. Mohler ML, Bohl CE, Jones A, Coss CC, Narayanan R et al. Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit. J Med Chem 2009; 52: 3597-617.
55. Narayanan R, Mohler ML, Bohl CE, Miller DD, Dalton JT. Selective androgen receptor modulators in preclinical and clinical development. Nucl Recept Signal 2008; 6: e010.
56. Jones A, Hwang DJ, Narayanan R, Miller DD, Dalton JT. Effects of a novel selective androgen receptor modulator on dexamethasone-induced and hypogonadism-induced muscle atrophy. Endocrinology 2010; 151: 3706-19.